NPIT
CRL icon

National Penn Investors Trust’s Charles River Laboratories CRL Stock Holding History

National Penn Investors Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-51,946
Closed -$2.75M – 198
2013
Q4 		$2.75M Sell
51,946
-1,791
-3% -$89.9K 0.31% 73
2013
Q3 		$2.49M Buy
53,737
+961
+2% +$44.1K 0.3% 77
2013
Q2 		$2.16M Buy
+52,776
New +$2.26M 0.28% 81

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

National Penn Investors Trust's CRL Position: Q1 2014 in Review

National Penn Investors Trust sold out of Charles River Laboratories (CRL) in Q1 2014, closing a stake of 51,946 shares — an estimated $2.75M sold.

National Penn Investors Trust first reported a position in CRL in Q2 2013 and held it in 3 quarters. The position peaked at $2.75M in Q4 2013. 258 funds tracked by Wall St. Rank hold CRL as of Q1 2014.

  • National Penn Investors Trust reported no remaining Charles River Laboratories position as of Q1 2014 after selling out during the quarter.
  • National Penn Investors Trust sold 51,946 Charles River Laboratories shares in Q1 2014, an estimated $2.75M.
  • National Penn Investors Trust first reported a position in Charles River Laboratories in Q2 2013 and held it in 3 quarters.
  • National Penn Investors Trust's Charles River Laboratories position peaked at $2.75M in Q4 2013.
  • 258 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2014.

Based on National Penn Investors Trust's 13F filing for Q1 2014, filed 29 Apr 2014.